The role of leukotrienes in alveolitis associated with scleroderma

被引：3
作者：
Simms, RW [1 ]
Korn, JH [1 ]
机构：
[1] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 06期
关键词：
BRONCHOALVEOLAR LAVAGE; SYSTEMIC-SCLEROSIS; GENE-EXPRESSION; LUNG-DISEASE;
D O I：
10.1002/art.11041
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1478 / 1480
页数：3
相关论文
共 50 条
  • [41] Multiple Sclerosis Associated with Systemic Sclerosis (Scleroderma): Case Report
    Almutairi, Aqeel
    Al-Jumah, Mohamed
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2020, 8 (07): : 1 - 3
  • [42] Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis
    Bogatkevich, Galina S.
    Atanelishvili, Ilia
    Bogatkevich, Andrew M.
    Silver, Richard M.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (03) : 438 - 448
  • [43] Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis
    Tsuji, Hideaki
    Kuramoto, Nobuo
    Sasai, Tsuneo
    Shirakashi, Mirei
    Onizawa, Hideo
    Kitagori, Koji
    Akizuki, Shuji
    Nakashima, Ran
    Watanabe, Ryu
    Onishi, Akira
    Murakami, Kosaku
    Yoshifuji, Hajime
    Tanaka, Masao
    Hashimoto, Motomu
    Ohmura, Koichiro
    Morinobu, Akio
    RHEUMATOLOGY, 2022, 61 (10) : 4130 - 4135
  • [44] Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
    Tamby, M. C.
    Humbert, M.
    Guilpain, P.
    Servettaz, A.
    Dupin, N.
    Christner, J. J.
    Simonneau, G.
    Fermanian, J.
    Weill, B.
    Guillevin, L.
    Mouthon, L.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 799 - 807
  • [45] Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy
    Gigante, Antonietta
    Navarini, Luca
    Margiotta, Domenico
    Amoroso, Antonio
    Barbano, Biagio
    Cianci, Rosario
    Afeltra, Antonella
    Rosato, Edoardo
    MICROVASCULAR RESEARCH, 2017, 114 : 41 - 45
  • [46] Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies
    Harris, ML
    Rosen, A
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (06) : 778 - 784
  • [47] Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension
    Johnson, Sindhu R.
    Swinton, John R.
    Granton, John T.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (08) : 1584 - 1590
  • [48] Defining genetic risk factors for scleroderma-associated interstitial lung disease IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
    Stock, Carmel J. W.
    De Lauretis, Angelo
    Visca, Dina
    Daccord, Cecile
    Kokosi, Maria
    Kouranos, Vasilis
    Margaritopoulos, George
    George, Peter M.
    Molyneaux, Philip L.
    Nihtyanova, Svetlana
    Chua, Felix
    Maher, Toby M.
    Ong, Voon
    Abraham, David J.
    Denton, Christopher P.
    Wells, Athol U.
    Wain, Louise V.
    Renzoni, Elisabetta A.
    CLINICAL RHEUMATOLOGY, 2020, 39 (04) : 1173 - 1179
  • [49] A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center
    Giuggioli, D.
    Orlandi, M.
    Spinella, A.
    de Pinto, M.
    Lumetti, F.
    Amati, G.
    Secchi, O.
    Ariani, A.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (01)
  • [50] Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer-Associated Scleroderma
    Shah, Ami A.
    Hummers, Laura K.
    Casciola-Rosen, Livia
    Visvanathan, Kala
    Rosen, Antony
    Wigley, Fredrick M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (04) : 1053 - 1061
12345